Financial Ratios

LOTUS EYE HOSPITAL AND INSTITUTE LTD.

NSE : LOTUSEYEBSE : 532998ISIN CODE : INE947I01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE59.98-1.62 (-2.63 %)
PREV CLOSE ( ) 61.60
OPEN PRICE ( ) 60.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8637
TODAY'S LOW / HIGH ( )59.10 60.20
52 WK LOW / HIGH ( )44.1 110.9
NSE59.55-0.75 (-1.24 %)
PREV CLOSE( ) 60.30
OPEN PRICE ( ) 60.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25839
TODAY'S LOW / HIGH( ) 58.20 60.30
52 WK LOW / HIGH ( )48.5 111
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.961.440.750.510.34
   CEPS(Rs)3.392.641.871.711.81
   DPS(Rs)0.500.500.500.000.00
   Book NAV/Share(Rs)27.6926.2625.3424.6524.10
   Tax Rate(%)27.8627.0921.2926.86-12.77
Margin Ratios
   Core EBITDA Margin(%)16.3515.2511.239.828.39
   EBIT Margin(%)12.4511.076.584.172.19
   Pre Tax Margin(%)12.0110.526.153.591.63
   PAT Margin (%)8.677.674.842.631.84
   Cash Profit Margin (%)15.0014.1012.048.789.80
Performance Ratios
   ROA(%)6.584.992.711.891.25
   ROE(%)7.275.563.022.101.41
   ROCE(%)10.438.004.073.321.66
   Asset Turnover(x)0.760.650.560.720.68
   Sales/Fixed Asset(x)0.530.460.400.500.48
   Working Capital/Sales(x)4.945.474.168.7139.50
Efficiency Ratios
   Fixed Capital/Sales(x)1.892.172.522.002.08
   Receivable days6.976.407.906.419.03
   Inventory Days19.7719.1621.9519.2121.58
   Payable days81.7696.13106.9887.95110.55
Valuation Parameters
   PER(x)29.6237.1855.5745.5265.06
   PCE(x)17.1120.2322.3513.6112.23
   Price/Book(x)2.102.031.650.950.92
   Yield(%)0.860.941.190.000.00
   EV/Net Sales(x)2.392.632.391.031.14
   EV/Core EBITDA(x)12.7114.9917.708.5511.20
   EV/EBIT(x)19.1923.7336.3924.6751.89
   EV/CE(x)1.791.671.330.730.79
   M Cap / Sales2.572.852.691.191.20
Growth Ratio
   Net Sales Growth(%)20.9020.21-20.185.541.06
   Core EBITDA Growth(%)29.6255.74-10.3125.14-25.16
   EBIT Growth(%)35.94102.3125.78101.06-55.30
   PAT Growth(%)36.6390.3347.2950.37-59.47
   EPS Growth(%)36.6290.3347.2950.37-59.47
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.010.010.00
   Current Ratio(x)2.832.242.341.791.17
   Quick Ratio(x)2.301.832.031.430.79
   Interest Cover(x)28.6920.0915.527.133.93
   Total Debt/Mcap(x)0.000.000.000.010.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.